Table 2 Patient’s baseline clinical characteristics, N = 105

Duration of T2DM (years)^a

11.5 ± 8.5

 ≤ 10

53 (50.5)

 11–20

39 (37.1)

 21–30

8 (7.6)

 > 30

5 (4.8)

Comorbidities

 Hypertension

74 (70.5)

 Dyslipidaemia

50 (47.6)

 Ischaemic heart disease

12 (11.4)

 Cerebrovascular accident

2 (1.9)

 Renal impairment

13 (12.4)

 Liver impairment

9 (8.6)

 Heart failure

5 (4.8)

Diabetic complications

 Neuropathy

9 (8.6)

 Nephropathy

5 (4.8)

 Retinopathy

12 (11.4)

 All of the above

2 (1.9)

HbA1c (%)^a

8.5 ± 1.8

 < 6.5

8 (7.6)

 6.5–9.9

76 (72.4)

 ≥ 10

21 (20.0)

FBG (mmol/L)^a

9.1 ± 3.8

ALT (μmol/L)^a

31.0 ± 0.2

TC (mmol/L)^a

5.0 ± 4.0

TG (mmol/L)^a

1.9 ± 1.3

LDL (mmol/L)^a

2.6 ± 0.9

HDL (mmol/L)^a

1.2 ± 0.4